Does the use of recombinant AAV5 in pulmonary gene therapy lead to lung damage?
S.V. Martini, S.S. Fagundes, A.C. Schmidt, M. Avila, D.S. Ornellas, V.T. Ribas, H. Petrs-Silva, R. Linden, D.S. Faffe, S.E. Guggino, P.R.M. Rocco, W.A. Zin, M.M. MoralesVolume:
168
Year:
2009
Language:
english
Pages:
7
DOI:
10.1016/j.resp.2009.06.016
File:
PDF, 1.37 MB
english, 2009